Filter
370
Text search:
International
Pharmaceutical
Federation
Featured
Recommendations
35
New Publications
84
Language
Document type
No document type
189
Studies & Reports
76
Guidelines
54
Manuals
19
Strategic & Response Plan
16
Training Material
9
Fact sheets
3
Situation Updates
2
Resource Platforms
2
Countries / Regions
Global
24
Nigeria
16
India
16
Western and Central Europe
13
Ukraine
11
Kenya
8
South Africa
8
Eastern Europe
6
Sierra Leone
4
Ethiopia
4
Eastern Europe and Central Asia
4
Africa
4
Russia
4
Liberia
3
Uganda
3
Syria
3
Asia
3
Senegal
2
Cameroon
2
Zimbabwe
2
Philippines
2
Nepal
2
Tanzania
2
Rwanda
2
Brazil
2
Lesotho
2
Myanmar / Burma
2
Latin America and the Carribbean
2
Moldova
2
Kyrgyzstan
2
Guinea
1
Congo, Democratic Republic of
1
Mali
1
Ghana
1
Niger
1
South Sudan
1
Iraq
1
Jordan
1
Germany
1
Chad
1
Bangladesh
1
Namibia
1
North Macedonia
1
Serbia
1
Botswana
1
Venezuela
1
Albania
1
Armenia
1
Laos
1
Tajikistan
1
Bulgaria
1
Uzbekistan
1
Kazakhstan
1
Georgia
1
Turkmenistan
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
92
Clinical Guidelines
35
Key Resources
25
Public Health
21
Women & Child Health
11
Pharmacy & Technologies
8
Capacity Building
7
Toolboxes
Pharmacy
33
Mental Health
32
HIV
30
TB
30
AMR
28
COVID-19
23
NCDs
20
Conflict
14
Rapid Response
12
Global Health Education
9
Planetary Health
8
Caregiver
7
Ebola & Marburg
5
Refugee
5
Specific Hazards
4
NTDs
4
Health Financing Toolbox
3
2.0 Rapid Response
3
Disability
2
Polio
2
Natural Hazards
2
Zika
1
Bulletin of the World Health Organization; Type: Perspectives
Article ID: BLT.19.24843
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro
...
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
A survey of prevention, testing and treatment policies and practices
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs
...
Improving Infection Prevention and Control Practices at Health Facilities in Resource-Limited Settings
recommended
SIAPS Technical Report. This report summarizes key accomplishments and lessons learned in implementing SIAPS’ approach to improving IPC practices in four countries: South Africa, Namibia, Jordan, and Ethiopia. All activities address SIAPS’s overall objective to build or enhance national and faci
...
STGs are designed to assist health care professionals in making decisions about appropriate, effective patient care. However, health managers often have trouble setting and meeting the high standards required of modern, developed health care systems. With stakeholders expressing concern over issues
...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future
...
The mounting burden of type 2 diabetes is a major concern in healthcare systems worldwide. The purpose of this study is to investigate the trend of type 2 diabetes from 1990 to 2019 in Asia.
This guide is available in English, French, Spanish, Russian, Arabic and Chinese
This guide consolidates COVID-19 guidance for human resources for health managers and policy-makers at national, subnational and facility levels to design, manage and preserve the workforce necessary to manage the COVI
...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the
...